健保資料庫研究團隊 - 盤點2020發表SCI論文

盤點2020發表SCI論文

🙂 盤點2020 ，在學術上，我們團隊是大爆發的一年，

          總計發表80篇SCI論文，其中5分以上37篇!

👍 這個成就，歸因於團隊合作的平台發揮功能，持續引進新血，

         幫助指導老師群擴展枝葉...。

👨‍⚕️ 當然，新冠肺炎的疫情讓大家減少雜務，專心學術也是一個原因。

回首：就是感恩，感謝團隊的支持與努力！

展望：造福世人，重質不重量！

📝 代表性的11篇論文如下：

1: Xue YH, You LT, Ting HF, Chen YW, Sheng ZY, Xie YD, Wang YH, Chiou JY, Wei JC. Increased risk of rheumatoid arthritis among patients with endometriosis: a nationwide population-based cohort study. Rheumatology (Oxford). 2020 Dec17:keaa784. doi: 10.1093/rheumatology/keaa784.

2: Tseng JC, Wei JC, Deodhar A, Martin R, Porter B, McCreddin S, Talloczy Z. Secukinumab Demonstrates Sustained Efficacy and Safety in a Taiwanese Subpopulation With Active Ankylosing Spondylitis: Four-Year Results From a Phase 3 Study, MEASURE 1. Front Immunol. 2020 Nov 26;11:561748. doi:10.3389/fimmu.2020.561748.

3: Chen ML, Wang SH, Wei JC, Yip HT, Hung YM, Chang R. The Impact of Human Papillomavirus Infection on Skin Cancer: A Population-Based Cohort Study. Oncologist. 2020 Nov 15. doi: 10.1002/onco.13593.

4: Wang S, Tsou HK, Chiou JY, Wang YH, Zhang Z, Wei JC. Increased Risk of Inflammatory Bowel Disease Among Patients With Ankylosing Spondylitis: A 13-Year Population-Based Cohort Study. Front Immunol. 2020 Oct 2;11:578732. doi:10.3389/fimmu.2020.578732.

5: Chang R, Chen ML, Lin CL, Hung YM, Wei JC. Association of Infection With Human Papillomavirus and Development of End-Stage Kidney Disease in Taiwan. JAMA Netw Open. 2020 Oct 1;3(10):e2022107. doi: 10.1001/jamanetworkopen.2020.22107.

6: Mo HY, Wei JCC, Chen XH, Chen HH. Increased risk of systemic lupus erythematosus in patients with autoimmune haemolytic anaemia: a nationwide population-based cohort study. Ann Rheum Dis. 2020 Sep 22:annrheumdis-2020-218886. doi: 10.1136/annrheumdis-2020-218886.

7: Chen ML, Kao WM, Huang JY, Hung YM, Wei JC. Human papillomavirus infection associated with increased risk of new-onset psoriasis: a nationwide population-based cohort study. Int J Epidemiol. 2020 Jun 1;49(3):786-797. doi:10.1093/ije/dyaa027.

8: Wu CY, Tan M, Huang JY, Chiou JY, Wei JC.  Hydroxychloroquine is neutral in risk of chronic kidney disease in patients with systemic lupus erythematosus. Ann Rheum Dis. 2020 May 20:annrheumdis-2020-217728. doi:10.1136/annrheumdis-2020-217728.

9: Wei CY, Lin JY, Wang YT, Huang JY, Wei JC, Chiou JY. Risk of ankylosing spondylitis following human papillomavirus infection: A nationwide, population-based, cohort study. J Autoimmun. 2020 Sep;113:102482. doi:10.1016/j.jaut.2020.102482.

10: Zhu FX, Huang JY, Ye Z, Wen QQ, Wei JC. Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: a population-based cohort study. Ann Rheum Dis. 2020 Jun;79(6):793-799. doi:10.1136/annrheumdis-2020-217013.

11: Dougados M, Wei JC, Landewé R, Sieper J, Baraliakos X, Van den Bosch F, Maksymowych WP, Ermann J, Walsh JA, Tomita T, Deodhar A, van der Heijde D, Li X, Zhao F, Bertram CC, Gallo G, Carlier H, Gensler LS; COAST-V and COAST-W Study Groups. Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W). Ann Rheum Dis. 2020Feb;79(2):176-185. doi: 10.1136/annrheumdis-2019-216118.